Fig. 2From: Thrombelastometry guided blood-component therapy after cardiac surgery: a randomized studyA cumulative cost analysis of all blood component products in the subgroup of patients with ālongā CPB-times revealed cost savings of 619.8 ā¬ per patient treated in the āpoint-of-careā 4-chamber ROTEMĀ®. Costs savings were not annihilated by the additional costs for ROTEMĀ® testing (on average: 68.3 ā¬ per patient)Back to article page